GLMD biotech catalysts & pipeline

GALMED PHARMACEUTICALS LTD · Data as of 2026-09-08

Upcoming catalysts

CG-100 — NDA/BLA submission

2026

In addition to generating top-line revenue already in 2026, "real-life" data from patients using CG-100 is planned to be submitted to the FDA to support Colospan' s Pivotal study

Source filing

Explore the free biotech catalyst calendar